Transgenic Mouse Models Establish a Protective Role of Type 1 IFN Response in SARS-CoV-2 infection-related Immunopathology
N. R. Chauhan, S. Kundu, R. Bal, D. Chattopadhyay, S. Mehto, R. Sahu, R. Yadav, S. Krishna, K. K. Jena, S. Satapathy, K. C. Murmu, B. Singh, S. K. Das, S. Jena, K. H. Harshan, G. H. Syed, P. Prasad, S. Chauhan
Abstract
Type 1 interferon (IFN-I) response is the first line of host defense against invading viruses. In the absence of definite mouse models, the role of IFN-I in SARS-CoV-2 infections remained to be perplexing. Here, we developed two mouse models, one with constitutively high IFN-I response (hACE2; Irgm1-/-) and the other with dampened IFN-I response (hACE2; Ifnar1-/-) to comprehend the role of IFN-I response during SARS-CoV-2 invasion. We found that hACE2; Irgm1-/- mice were resistant to lethal SARS-CoV-2 infection with substantially reduced cytokine storm and immunopathology. In striking contrast, a severe SARS-CoV-2 infection along with immune cells infiltration, inflammatory response, and enhanced pathology was observed in the lungs of hACE2; Ifnar1-/- mice. Additionally, hACE2; Ifnar1-/- mice were highly susceptible to SARS-CoV-2 neuroinvasion in the brain accompanied by immune cell infiltration, microglia/astrocytes activation, cytokine response, and demyelination of neurons. The hACE2; Irgm1-/- Ifnar1-/- double knockout mice or hACE2; Irgm1-/- mice treated with STING or RIPK2 pharmacological inhibitors displayed loss of the protective phenotypes observed in hACE2; Irgm1-/- mice suggesting that heightened IFN-I response accounts for the observed immunity. Taken together, we explicitly demonstrate that IFN-I protects from lethal SARS-CoV-2 infection, and Irgm1 (IRGM) could be an excellent therapeutic target. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=133 SRC="FIGDIR/small/520843v1_ufig1.gif" ALT="Figure 1"> View larger version (51K): org.highwire.dtl.DTLVardef@a3aad4org.highwire.dtl.DTLVardef@12452fcorg.highwire.dtl.DTLVardef@1c43dc0org.highwire.dtl.DTLVardef@b2167d_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
B. Goldman-Israelow, E. Song, … A. Iwasaki·bioRxiv·May 27, 2020
- Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
T. N. Hoang, E. G. Viox, … M. Paiardini·bioRxiv·Oct 21, 2022
- Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19
S. Robertson, O. Bedard, … S. Best·bioRxiv·Sep 17, 2021
- ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
D. J. Rawle, T. T. Le, … A. Suhrbier·bioRxiv·Feb 9, 2021
- Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses
A. Banerjee, N. El-Sayes, … K. Mossman·bioRxiv·Jun 18, 2020
- SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function
Emma S Winkler, Adam L Bailey, … Michael S Diamond·bioRxiv·Jul 9, 2020